Integrated Wealth Concepts LLC Gilead Sciences, Inc. Transaction History

Integrated Wealth Concepts LLC

$7.83 Billion
Q3 2024

A detailed history of Integrated Wealth Concepts LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Integrated Wealth Concepts LLC holds 25,493 shares of GILD stock, worth $2.33 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

25,493

Previous 25,744 0.97%

Holding current value

$2.33 Million

Previous $1.77 Million 20.95%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $16,714 - $21,081	-251 Reduced 0.97%	25,493 $2.14 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $58,476 - $67,486	926 Added 3.73%	25,744 $1.77 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $15,676 - $19,116	219 Added 0.89%	24,818 $1.82 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $264,944 - $300,453	-3,616 Reduced 12.82%	24,599 $1.99 Million
Q3 2023 Nov 15, 2023	BUY	$73.94 - $80.67 $24,991 - $27,266	338 Added 1.21%	28,215 $2.11 Million
Q2 2023 Aug 15, 2023	SELL	$76.01 - $86.7 $320,762 - $365,874	-4,220 Reduced 13.15%	27,877 $2.15 Million
Q1 2023 May 03, 2023	BUY	$77.31 - $88.08 $1.11 Million - $1.27 Million	14,376 Added 81.12%	32,097 $2.66 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $90,426 - $129,820	-1,451 Reduced 7.57%	17,721 $1.52 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $22,744 - $25,979	-382 Reduced 1.95%	19,172 $1.18 Million
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $227,647 - $256,399	-3,944 Reduced 16.78%	19,554 $1.21 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $176,713 - $221,441	3,051 Added 14.92%	23,498 $1.4 Million
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $100,888 - $114,510	1,555 Added 8.23%	20,447 $1.49 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $452,846 - $488,570	6,690 Added 54.83%	18,892 $1.32 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $17,517 - $19,140	276 Added 2.31%	12,202 $840,000
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $26,340 - $30,053	-439 Reduced 3.55%	11,926 $771,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $1,416 - $1,613	25 Added 0.2%	12,365 $720,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $317,765 - $399,535	5,117 Added 70.84%	12,340 $780,000
Q2 2020 Jul 30, 2020	BUY	$72.34 - $84.0 $218,177 - $253,344	3,016 Added 71.69%	7,223 $556,000
Q1 2020 May 18, 2020	SELL	$62.63 - $80.22 $78,162 - $100,114	-1,248 Reduced 22.88%	4,207 $315,000
Q4 2019 Feb 20, 2020	BUY	$61.62 - $67.78 $57,861 - $63,645	939 Added 20.79%	5,455 $354,000
Q3 2019 Nov 15, 2019	SELL	$62.51 - $69.0 $31,630 - $34,914	-506 Reduced 10.08%	4,516 $286,000
Q2 2019 Aug 15, 2019	BUY	$61.87 - $69.38 $310,711 - $348,426	5,022 New	5,022 $322,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $156,193 - $203,820	-2,580 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $183,902 - $203,613	2,580 New	2,580 $201,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.

Account

Integrated Wealth Concepts LLC Gilead Sciences, Inc. Transaction History